To address the growing burden of cancer, continued work in prevention, screening, early detection and treatment will be necessary. To effectively meet the growing demand for care, the leaders of provincially designated cancer programs have agreed to focus on sustainability, operational efficiency, risk management and quality and safety. As part of the CAPCA Strategic Plan 2015-2020 the association has committed to work across provincial discipline-specific and organizational boundaries in pursuit of a sustainable, efficient and safe cancer delivery system.

Cancer Drug Funding

The pan-Canadian Cancer Drug Funding Sustainability Initiative was lauched and led by CAPCA to support the provinces in drug funding decision-making. It built on existing drug evaluation by the Canadian Agency for Drugs and Technologiesin Health (CADTH)/pan-Canadian Oncology Drug Review (pCODR) and the Institut national d’excellence en santé et services sociaux (INESSS), and price negotiation by the pan-Canadian Pharmaceutical Alliance (pCPA). This work launched in 2016 to ensure Canadian patients continue to have access to new and effective cancer treatments and that our cancer system is achieving maximum value for money invested. For more information please check out Cancer Drug Funding.

Oral Cancer Drug Therapy

In May 2015 CAPCA released the Oral Cancer Drug Therapy Safe Use and Safe Handling Guideline which was followed with the Safe Use and Handling of Oral Anti-Cancer Drugs in Community Pharmacy: A Pan-Canadian Consensus Guideline in 2016. For more information on this work please check out Oral Cancer Drug Therapy.

Patient Safety

Through the establishment of the Systemic Therapy Safety Council in 2007, CAPCA has made a marked impact in the improvement of patient safety through the creation of Guidelines for Developing Ambulatory Chemotherapy Preprinted Orders, and support for national incident reporting systems for both medication and radiation treatment incidents. For more information on this work please check out Patient Safety.